Cencora Inc
COR273.890USD
-1.070-0.38%
Handelsschluss 04/09, 16:00（ET）Kurse um 15 Minuten verzögert
53.39BMarktkapitalisierung
38.24KGV TTM
mehr Informationen über Cencora Inc Unternehmen
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Unternehmensinformationen
Unternehmens-codeCOR
Name des UnternehmensCencora Inc
IPO-datumMay 28, 1996
Gegründet am2001
CEODr. Robert P. (Bob) Mauch, Ph.D.
Anzahl der mitarbeiter42000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 28
Addresse1 West First Avenue
StadtCONSHOHOCKEN
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl19428
Telefon16107277000
Websitehttps://www.cencora.com/
Unternehmens-codeCOR
IPO-datumMay 28, 1996
Gegründet am2001
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
317.91K
-0.63%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.11K
+3.70%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.66K
-21.96%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
Mr. Francois Mandeville
Mr. Francois Mandeville
Executive Vice President - Strategy and M&A
Executive Vice President - Strategy and M&A
--
--
Mr. D. Mark Durcan
Mr. D. Mark Durcan
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
317.91K
-0.63%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.11K
+3.70%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.66K
-21.96%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
10.96%
BlackRock Institutional Trust Company, N.A.
5.56%
Walgreens Boots Alliance Inc
5.36%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.15%
Other
69.53%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
10.96%
BlackRock Institutional Trust Company, N.A.
5.56%
Walgreens Boots Alliance Inc
5.36%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.15%
Other
69.53%
Art
Aktionäre
Anteil
Investment Advisor
39.88%
Investment Advisor/Hedge Fund
38.06%
Corporation
5.36%
Research Firm
4.22%
Hedge Fund
3.92%
Pension Fund
2.08%
Bank and Trust
1.94%
Sovereign Wealth Fund
1.19%
Family Office
1.17%
Other
2.16%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2167
189.96M
98.06%
-8.34M
2024Q4
2214
199.54M
103.03%
-6.12M
2024Q3
2134
200.05M
102.56%
+474.02K
2024Q2
2090
200.10M
100.34%
-7.14M
2024Q1
2068
201.37M
100.95%
-1.37M
2023Q4
1982
202.46M
101.40%
+179.01K
2023Q3
1885
197.70M
97.79%
-2.16M
2023Q2
1870
195.01M
96.41%
-1.88M
2023Q1
1823
192.70M
95.24%
-7.51M
2022Q4
1797
190.05M
93.86%
-247.07K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
21.22M
10.96%
+5.67K
+0.03%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.77M
5.56%
+112.08K
+1.05%
Dec 31, 2024
Walgreens Boots Alliance Inc
10.38M
5.36%
-2.19M
-17.42%
Mar 21, 2025
T. Rowe Price Associates, Inc.
8.61M
4.44%
+71.27K
+0.84%
Dec 31, 2024
State Street Global Advisors (US)
8.03M
4.15%
-14.00K
-0.17%
Dec 31, 2024
Wellington Management Company, LLP
5.06M
2.61%
-135.53K
-2.61%
Dec 31, 2024
Boston Partners
5.01M
2.58%
+125.61K
+2.57%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.33M
2.23%
+130.21K
+3.10%
Dec 31, 2024
JP Morgan Asset Management
3.45M
1.78%
+46.78K
+1.37%
Dec 31, 2024
Capital Research Global Investors
2.90M
1.5%
+4.61K
+0.16%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
VanEck Pharmaceutical ETF
5.16%
AdvisorShares Focused Equity ETF
4.3%
Invesco Dorsey Wright Healthcare Momentum ETF
3.79%
VictoryShares US Multi-Factor Minimum Vol ETF
3.67%
Amplify Cash Flow Dividend Leaders ETF
3.56%
Indexperts Quality Earnings Focused ETF
3.04%
VanEck Retail ETF
2.81%
First Trust Consumer Staples Alphadex Fund
2.78%
Amplify Cash Flow High Income ETF
2.74%
Counterpoint Quantitative Equity ETF
2.37%
Mehr Anzeigen
VanEck Pharmaceutical ETF
Anteil5.16%
AdvisorShares Focused Equity ETF
Anteil4.3%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil3.79%
VictoryShares US Multi-Factor Minimum Vol ETF
Anteil3.67%
Amplify Cash Flow Dividend Leaders ETF
Anteil3.56%
Indexperts Quality Earnings Focused ETF
Anteil3.04%
VanEck Retail ETF
Anteil2.81%
First Trust Consumer Staples Alphadex Fund
Anteil2.78%
Amplify Cash Flow High Income ETF
Anteil2.74%
Counterpoint Quantitative Equity ETF
Anteil2.37%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.92B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
May 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023
May 12, 2023
May 30, 2023
May 11, 2023
Feb 01, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023
Feb 10, 2023
Feb 27, 2023
Feb 09, 2023
Nov 04, 2022
COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten